Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells

por Roscher, Mareike, Hormann, Inis, Leib, Oliver, Marx, Sebastian, Moreno, Josue, Miltner, Erich, Friesen, Claudia
Publicado 2013